Trump FDA Nominee Heidi Overton Faces Scrutiny Over Abortion Pill Access
· World · NBC News
Dr. Heidi Overton, President Donald Trump’s nominee to lead the Food and Drug Administration, is scheduled for a Senate confirmation hearing this Thursday. The Senate Health, Education, Labor and Pensions Committee is expected to question her on abortion rights, specifically regarding the regulation of the abortion pill mifepristone. Committee chair Senator Bill Cassidy has publicly pressured the FDA to reverse rules allowing the drug to be prescribed via telemedicine and delivered by mail. Overton, a preventive medicine physician and former official at the America First Policy Institute, has previously described medication abortion as dangerous to women. If confirmed, she would replace the agency's leadership, which has remained without a permanent commissioner since May.
Why it matters
Overton's confirmation could lead to significant shifts in federal reproductive health policy, including potential restrictions on the accessibility of mifepristone across the United States.
Read the original report — NBC News
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.